JOHNSON KERYN,SUN CYNTHIA,HUBL ULRIKE,BILLAKANTI JAGANMOHAN
申请号：
NZ61549512
公开号：
NZ615495A
申请日:
2012.06.22
申请国别(地区):
NZ
年份:
2015
代理人:
摘要：
Discloses the use of a functional fragment of a major royal jelly protein (MRJP) for preparation of a medicament for reducing inflammation in a cellular tissue in a patient wherein the functional fragment has been isolated, enriched, synthesized, or recombinantly produced wherein the functional fragment comprises 2 to 20 amino acids of the last 20 amino acids at the C-terminus of the protein and wherein a lysine amino acid residue of the functional fragment has been chemically modified by methylglyoxal (MGO).
